| Matthew Martin Peterson, MD | |
|
170 N 1100 E, American Fork, UT 84003-2096 | |
| (801) 855-3300 | |
| Not Available |
| Full Name | Matthew Martin Peterson |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 12 Years |
| Location | 170 N 1100 E, American Fork, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306104534 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | A141623 (California) | Secondary |
| 207L00000X | Anesthesiology | 11119648-1205 (Utah) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nph Anesthesia Of Utah Llc | 9537584313 | 96 |
News Archive
A targeted opioid that only treats diseased tissues and spares healthy tissues relieves pain from inflammatory bowel disease without causing side effects, according to new research published in the journal Gut.
Today, the U.S. Food and Drug Administration approved Truvada (emtricitabine/tenofovir disoproxil fumarate), the first drug approved to reduce the risk of HIV infection in uninfected individuals who are at high risk of HIV infection and who may engage in sexual activity with HIV-infected partners. Truto reduce the risk of sexually-acquired HIV infection in adults at high risk.
MedClean Technologies, Inc. today announced the Company has entered into a preferred stock purchase agreement with Socius Capital Group, LLC, a Delaware limited liability company, doing business as Socius Life Sciences Capital Group, LLC. Pursuant to the Purchase Agreement, MedClean will receive up to $7.5 million in capital.
Publication in Nature advanced on line publication : researchers at the Université libre de Bruxelles, ULB identify distinct types of stem cells that contribute to mammary gland development and maintenance.
A large study of middle-aged women shows that age-related changes in skeletal muscle are part of everyday life for women in their fifties.
› Verified 9 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629260880 PECOS PAC ID: 1850209420 Enrollment ID: O20031105000079 |
News Archive
A targeted opioid that only treats diseased tissues and spares healthy tissues relieves pain from inflammatory bowel disease without causing side effects, according to new research published in the journal Gut.
Today, the U.S. Food and Drug Administration approved Truvada (emtricitabine/tenofovir disoproxil fumarate), the first drug approved to reduce the risk of HIV infection in uninfected individuals who are at high risk of HIV infection and who may engage in sexual activity with HIV-infected partners. Truto reduce the risk of sexually-acquired HIV infection in adults at high risk.
MedClean Technologies, Inc. today announced the Company has entered into a preferred stock purchase agreement with Socius Capital Group, LLC, a Delaware limited liability company, doing business as Socius Life Sciences Capital Group, LLC. Pursuant to the Purchase Agreement, MedClean will receive up to $7.5 million in capital.
Publication in Nature advanced on line publication : researchers at the Université libre de Bruxelles, ULB identify distinct types of stem cells that contribute to mammary gland development and maintenance.
A large study of middle-aged women shows that age-related changes in skeletal muscle are part of everyday life for women in their fifties.
› Verified 9 days ago
| Entity Name | Lone Peak Anesthesia Lc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083622641 PECOS PAC ID: 9436057346 Enrollment ID: O20031229000973 |
News Archive
A targeted opioid that only treats diseased tissues and spares healthy tissues relieves pain from inflammatory bowel disease without causing side effects, according to new research published in the journal Gut.
Today, the U.S. Food and Drug Administration approved Truvada (emtricitabine/tenofovir disoproxil fumarate), the first drug approved to reduce the risk of HIV infection in uninfected individuals who are at high risk of HIV infection and who may engage in sexual activity with HIV-infected partners. Truto reduce the risk of sexually-acquired HIV infection in adults at high risk.
MedClean Technologies, Inc. today announced the Company has entered into a preferred stock purchase agreement with Socius Capital Group, LLC, a Delaware limited liability company, doing business as Socius Life Sciences Capital Group, LLC. Pursuant to the Purchase Agreement, MedClean will receive up to $7.5 million in capital.
Publication in Nature advanced on line publication : researchers at the Université libre de Bruxelles, ULB identify distinct types of stem cells that contribute to mammary gland development and maintenance.
A large study of middle-aged women shows that age-related changes in skeletal muscle are part of everyday life for women in their fifties.
› Verified 9 days ago
| Entity Name | Rocky Mountain Anesthesiology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487683215 PECOS PAC ID: 6305809492 Enrollment ID: O20041109001170 |
News Archive
A targeted opioid that only treats diseased tissues and spares healthy tissues relieves pain from inflammatory bowel disease without causing side effects, according to new research published in the journal Gut.
Today, the U.S. Food and Drug Administration approved Truvada (emtricitabine/tenofovir disoproxil fumarate), the first drug approved to reduce the risk of HIV infection in uninfected individuals who are at high risk of HIV infection and who may engage in sexual activity with HIV-infected partners. Truto reduce the risk of sexually-acquired HIV infection in adults at high risk.
MedClean Technologies, Inc. today announced the Company has entered into a preferred stock purchase agreement with Socius Capital Group, LLC, a Delaware limited liability company, doing business as Socius Life Sciences Capital Group, LLC. Pursuant to the Purchase Agreement, MedClean will receive up to $7.5 million in capital.
Publication in Nature advanced on line publication : researchers at the Université libre de Bruxelles, ULB identify distinct types of stem cells that contribute to mammary gland development and maintenance.
A large study of middle-aged women shows that age-related changes in skeletal muscle are part of everyday life for women in their fifties.
› Verified 9 days ago
| Entity Name | North Valley Anesthesia, Lc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780908152 PECOS PAC ID: 9133315252 Enrollment ID: O20101201000020 |
News Archive
A targeted opioid that only treats diseased tissues and spares healthy tissues relieves pain from inflammatory bowel disease without causing side effects, according to new research published in the journal Gut.
Today, the U.S. Food and Drug Administration approved Truvada (emtricitabine/tenofovir disoproxil fumarate), the first drug approved to reduce the risk of HIV infection in uninfected individuals who are at high risk of HIV infection and who may engage in sexual activity with HIV-infected partners. Truto reduce the risk of sexually-acquired HIV infection in adults at high risk.
MedClean Technologies, Inc. today announced the Company has entered into a preferred stock purchase agreement with Socius Capital Group, LLC, a Delaware limited liability company, doing business as Socius Life Sciences Capital Group, LLC. Pursuant to the Purchase Agreement, MedClean will receive up to $7.5 million in capital.
Publication in Nature advanced on line publication : researchers at the Université libre de Bruxelles, ULB identify distinct types of stem cells that contribute to mammary gland development and maintenance.
A large study of middle-aged women shows that age-related changes in skeletal muscle are part of everyday life for women in their fifties.
› Verified 9 days ago
| Entity Name | Nph Anesthesia Of Utah Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366077273 PECOS PAC ID: 9537584313 Enrollment ID: O20200811001268 |
News Archive
A targeted opioid that only treats diseased tissues and spares healthy tissues relieves pain from inflammatory bowel disease without causing side effects, according to new research published in the journal Gut.
Today, the U.S. Food and Drug Administration approved Truvada (emtricitabine/tenofovir disoproxil fumarate), the first drug approved to reduce the risk of HIV infection in uninfected individuals who are at high risk of HIV infection and who may engage in sexual activity with HIV-infected partners. Truto reduce the risk of sexually-acquired HIV infection in adults at high risk.
MedClean Technologies, Inc. today announced the Company has entered into a preferred stock purchase agreement with Socius Capital Group, LLC, a Delaware limited liability company, doing business as Socius Life Sciences Capital Group, LLC. Pursuant to the Purchase Agreement, MedClean will receive up to $7.5 million in capital.
Publication in Nature advanced on line publication : researchers at the Université libre de Bruxelles, ULB identify distinct types of stem cells that contribute to mammary gland development and maintenance.
A large study of middle-aged women shows that age-related changes in skeletal muscle are part of everyday life for women in their fifties.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew Martin Peterson, MD 170 N 1100 E, American Fork, UT 84003-2096 Ph: (801) 855-3300 | Matthew Martin Peterson, MD 170 N 1100 E, American Fork, UT 84003-2096 Ph: (801) 855-3300 |
News Archive
A targeted opioid that only treats diseased tissues and spares healthy tissues relieves pain from inflammatory bowel disease without causing side effects, according to new research published in the journal Gut.
Today, the U.S. Food and Drug Administration approved Truvada (emtricitabine/tenofovir disoproxil fumarate), the first drug approved to reduce the risk of HIV infection in uninfected individuals who are at high risk of HIV infection and who may engage in sexual activity with HIV-infected partners. Truto reduce the risk of sexually-acquired HIV infection in adults at high risk.
MedClean Technologies, Inc. today announced the Company has entered into a preferred stock purchase agreement with Socius Capital Group, LLC, a Delaware limited liability company, doing business as Socius Life Sciences Capital Group, LLC. Pursuant to the Purchase Agreement, MedClean will receive up to $7.5 million in capital.
Publication in Nature advanced on line publication : researchers at the Université libre de Bruxelles, ULB identify distinct types of stem cells that contribute to mammary gland development and maintenance.
A large study of middle-aged women shows that age-related changes in skeletal muscle are part of everyday life for women in their fifties.
› Verified 9 days ago
Michael Dean Taylor, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 170 N 1100 E, American Fork, UT 84003 Phone: 801-763-3300 Fax: 678-285-6777 | |
Dr. Jonathan Taylor Meyers, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 170 N 1100 E, American Fork, UT 84003 Phone: 801-855-3300 |